Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/orexo-q2-2024-interim-report-302199082.html
https://www.prnewswire.com/news-releases/orexo-abs-sustainability-work-ranked-among-top-5-by-ecovadis-302193098.html
https://www.prnewswire.com/news-releases/orexo-invitation-to-presentation-of-the-q2-2024-interim-report-302190771.html
https://www.prnewswire.com/news-releases/orexo-publishes-prospectus-and-applies-for-admission-to-trading-of-social-bonds-on-nasdaq-stockholm-302142316.html
https://www.prnewswire.com/news-releases/orexo-q1-2024-interim-report-302139334.html
https://www.prnewswire.com/news-releases/report-from-orexo-abs-annual-general-meeting-26-april-2024-302128840.html
https://www.indianpharmapost.com/news/orexo-extends-patent-protection-for-its-nasal-epinephrine-powder-product-ox640-in-the-us-15552
https://www.prnewswire.com/news-releases/orexo-extends-patent-protection-for-its-nasal-epinephrine-powder-product-ox640-in-the-us-302119102.html
https://www.prnewswire.com/news-releases/orexo-announces-that-the-condition-for-early-redemption-of-its-existing-bonds-has-been-fulfilled-302105698.html
https://www.prnewswire.com/news-releases/orexo-publishes-the-annual-and-sustainability-report-for-2023-302102281.html